Skip to content

Monitoring of Sleep and Behavior of Children 3-7 Years Old Receiving Parent-Child Interaction Therapy With the Help of Artificial Intelligence

PISTACHIO (Preemption Of Disruptive Behavior In Children) Real-Time Monitoring Of Sleep And Behavior Of Children 3-7-Year-Old Receiving Parent Child Interaction Therapy Augmented With Artificial Intelligence Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05077722
Acronym
PISTACHIo
Enrollment
100
Registered
2021-10-14
Start date
2022-03-24
Completion date
2023-12-01
Last updated
2024-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-deficit Hyperactivity, Disruptive Behavior, Oppositional Defiant Disorder

Keywords

Emotional Behavioral Dyscontrol

Brief summary

The purpose of this study is to develop an innovative wearable tracking protocol that will use Artificial Intelligence (AI) technology to monitor sleep and behavior of 3-7 year old children.

Interventions

DEVICEGarmin

A smartwatch device that measures subjects level of activity, heartrate, respirations and quality of your sleep at night. Artificial intelligence will be applied to analyze all the data over the course of 12 weeks to monitor and attempt to predict the onset of tantrums or disruptive behavior. Subjects are required to wear the watch at least 70% of the day and night each day for 70% of days during 12 weeks of treatment.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
3 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

- Children: * Ages 3-7. * Outpatients or Inpatients. * Any gender, race or ethnicity. * Able to provide developmentally appropriate informed assent, and legal guardians able to provide informed consent . * EBP Severity rated above the clinically significant range (≥120; T-score ≥ 60) (Eyberg Child Behavior Inventory- ECBI; Eyberg & Pincus, 1999). * Need for more intensive behavioral treatments such as ER visit for behavioral dyscontrol or hospitalization will not be exclusionary or exit criteria. * Families approached for participation will be asked to commit to complete the treatment. * At least one primary caregiver and the identified child will have to be able to speak and understand English.

Exclusion criteria

- Children: * Formal diagnosis of Severe Intellectual disability, Autistic Spectrum Disorder Level 3, or a psychotic disorder for the child. * Parents not consenting to the study. * Parents or child is not able to adhere to the study protocol. * A Child who is reasonable expected to be unable to tolerate wearing the Garmin device for at least 70% of the time during the day and night 70% of the days during the treatment (12 weeks). This is based on the principal investigator's discretion. * Unable to speak and understand English. * Refusal or withdrawal of consent, inability, or unwillingness to adhere to study procedures. * Children in foster care. Inclusion Criteria - Adults: * Agree to wear Garmin watch. * Ages 18-99. * Any gender, race, ethnicity. * Able to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Frequency of Garmin use12 weeksNumber of days participants wear the Garmin smartwatch

Secondary

MeasureTime frameDescription
Eyberg Child Behavior Inventory12 weeksThe Eyberg Child Behavior Inventory questionnaire is measured on two subscales for a series of phrases that describe a children's behavior. The first subscale is for indicating the frequency of the behavior using a scale of 1= never to 7 = Always; the second subscale indicates yes = 1 or no = 0 for whether the behavior is currently a problem for them. Reponses are total with a higher score indicating greater severity of child's behavior.
Pediatric Sleep Questionnaire12 weeksPediatric Sleep Questionnaire to assess child's sleep with a series of 22 questions on a yes/no problem scale.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026